Schizophrenia and Disorders with Psychotic Features
Welcome,         Profile    Billing    Logout  
 86 Companies   134 Products   134 Products   85 Mechanisms of Action   5 Trials   1881 News 


«12345678910111213...3738»
  • ||||||||||  JNJ-39393406 / J&J
    Trial completion:  Novel Smoking Cessation Drug for Schizophrenia (clinicaltrials.gov) -  Mar 23, 2017   
    P2,  N=62, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed
  • ||||||||||  olanzapine / Generic mfg., ziprasidone / Generic mfg.
    Trial completion, Enrollment change, Trial primary completion date:  Antipsychotics and Gene Expression in Soft Tissues (clinicaltrials.gov) -  Mar 23, 2017   
    P4,  N=16, Completed, 
    Active, not recruiting --> Completed Suspended --> Completed | N=42 --> 16 | Trial primary completion date: Dec 2017 --> Jan 2017
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date, Adherence:  SPERA-S: Study on Psychoeducation Enhancing Results of Adherence in Schizophrenia (clinicaltrials.gov) -  Mar 15, 2017   
    P=N/A,  N=112, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed | N=280 --> 112 | Trial primary completion date: Jun 2015 --> May 2016
  • ||||||||||  JNJ-39393406 / J&J
    Enrollment closed, Trial primary completion date:  Novel Smoking Cessation Drug for Schizophrenia (clinicaltrials.gov) -  Mar 8, 2017   
    P2,  N=62, Active, not recruiting, 
    Phase classification: P1 --> P=N/A Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2017 --> Dec 2016
  • ||||||||||  Trial completion, Trial primary completion date:  Microfinance Intervention to Improve Health of Trauma Survivors in DRC (clinicaltrials.gov) -  Mar 3, 2017   
    P=N/A,  N=878, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Apr 2016 --> Sep 2016
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Transcranial Direct Current Stimulation (tDCS) and Hallucinations in Schizophrenia (clinicaltrials.gov) -  Mar 1, 2017   
    P=N/A,  N=46, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: Apr 2016 --> Sep 2016 Recruiting --> Completed | N=60 --> 46 | Trial primary completion date: Sep 2015 --> Apr 2016
  • ||||||||||  Trial primary completion date:  Cognitive Remediation and Sheltered Employment in Schizophrenia (clinicaltrials.gov) -  Feb 24, 2017   
    P=N/A,  N=260, Recruiting, 
    Recruiting --> Completed | N=60 --> 46 | Trial primary completion date: Sep 2015 --> Apr 2016 Trial primary completion date: Jan 2017 --> May 2018
  • ||||||||||  Enrollment closed:  Understanding How Cognitive Remediation Works (clinicaltrials.gov) -  Feb 23, 2017   
    P=N/A,  N=244, Active, not recruiting, 
    Trial primary completion date: Jan 2017 --> May 2018 Recruiting --> Active, not recruiting
  • ||||||||||  Trial completion, Trial primary completion date:  Omega-3 Dietary Supplements in Schizophrenia (clinicaltrials.gov) -  Feb 1, 2017   
    P=N/A,  N=50, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: Feb 2018 --> Feb 2017 Active, not recruiting --> Completed | Trial primary completion date: Jun 2016 --> Sep 2015
  • ||||||||||  Enrollment closed, Trial primary completion date:  Enhancing Cognitive Training Through Exercise After a First Schizophrenia Episode (clinicaltrials.gov) -  Feb 1, 2017   
    P=N/A,  N=60, Active, not recruiting, 
    Active, not recruiting --> Completed | Trial primary completion date: Jun 2016 --> Sep 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2016 --> Jul 2017
  • ||||||||||  Trial primary completion date:  Fingolimod in Schizophrenia Patients (clinicaltrials.gov) -  Jan 31, 2017   
    P2,  N=40, Active, not recruiting, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2016 --> Jul 2017 Trial primary completion date: Aug 2016 --> Aug 2017
  • ||||||||||  Enrollment closed, Trial primary completion date:  Neurobiology of a Mutation in Glycine Metabolism in Psychotic Disorders (clinicaltrials.gov) -  Jan 30, 2017   
    P2,  N=2, Active, not recruiting, 
    Trial primary completion date: Jul 2016 --> Jul 2017 Enrolling by invitation --> Active, not recruiting | Trial primary completion date: Nov 2016 --> May 2017
  • ||||||||||  Trial primary completion date:  DCS: Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine (clinicaltrials.gov) -  Jan 30, 2017   
    P=N/A,  N=2, Enrolling by invitation, 
    Enrolling by invitation --> Active, not recruiting | Trial primary completion date: Nov 2016 --> May 2017 Trial primary completion date: Feb 2017 --> Jul 2017
  • ||||||||||  Perseris (risperidone sustained-release 1-month depot) / Indivior, Reckitt Benckiser, HLS Therap
    Clinical:  Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia (clinicaltrials.gov) -  Jan 13, 2017   
    P3,  N=500, Completed, 
    Trial primary completion date: Aug 2016 --> Apr 2019 Active, not recruiting --> Completed
  • ||||||||||  L-threonic acid magnesium salt (NRCT-101) / Neurocentria
    Trial primary completion date:  Effect of MMFS-202-302 on Cognitive Enhancement in Schizophrenia (clinicaltrials.gov) -  Jan 12, 2017   
    P4,  N=60, Recruiting, 
    Active, not recruiting --> Completed Trial primary completion date: Sep 2016 --> Mar 2018
  • ||||||||||  Abilify Maintena (aripiprazole extended release) / Otsuka, Lundbeck
    Trial primary completion date:  ReLiAM: Real Life Assessment of Abilify Maintena (clinicaltrials.gov) -  Jan 10, 2017   
    P=N/A,  N=200, Terminated, 
    Trial primary completion date: Sep 2017 --> Jun 2017 Trial primary completion date: Nov 2016 --> Feb 2017
  • ||||||||||  Trial completion, Trial primary completion date:  Cognitive Training to Enhance VA Work Program Outcomes (clinicaltrials.gov) -  Dec 21, 2016   
    P3,  N=77, Completed, 
    N=80 --> 12 | Recruiting --> Terminated | Trial primary completion date: May 2017 --> Aug 2016; PI left institution Active, not recruiting --> Completed | Trial primary completion date: Dec 2015 --> Dec 2016
  • ||||||||||  Trial completion:  Work Activity Augmented by Cognitive Rehabilitation for Schizophrenia (clinicaltrials.gov) -  Dec 21, 2016   
    P2/3,  N=150, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: Dec 2015 --> Dec 2016 Active, not recruiting --> Completed
  • ||||||||||  minocycline / Generic mfg., clozapine / Generic mfg.
    Trial completion, Enrollment change:  Minocycline Augmentation to Clozapine (clinicaltrials.gov) -  Dec 12, 2016   
    P4,  N=14, Completed, 
    Recruiting --> Completed | Trial primary completion date: Mar 2017 --> Jul 2016 Recruiting --> Completed | N=35 --> 14
  • ||||||||||  Trial primary completion date:  Understanding How Cognitive Remediation Works (clinicaltrials.gov) -  Dec 9, 2016   
    P=N/A,  N=244, Recruiting, 
    Recruiting --> Completed | N=35 --> 14 Trial primary completion date: Nov 2018 --> Feb 2019
  • ||||||||||  valacyclovir / Generic mfg.
    Trial completion:  To Rescue Cognition With Valaciclovir (clinicaltrials.gov) -  Dec 1, 2016   
    P2,  N=24, Completed, 
    Recruiting --> Completed Recruiting --> Completed
  • ||||||||||  Trial completion:  Yoga as Cognitive Remediation in Schizophrenia (clinicaltrials.gov) -  Nov 29, 2016   
    P=N/A,  N=286, Completed, 
    Recruiting --> Completed Active, not recruiting --> Completed
  • ||||||||||  Abilify Maintena (aripiprazole extended release) / Otsuka, Lundbeck
    Enrollment change, Trial termination, Trial primary completion date:  ReLiAM: Real Life Assessment of Abilify Maintena (clinicaltrials.gov) -  Nov 22, 2016   
    P=N/A,  N=200, Terminated, 
    Active, not recruiting --> Completed N=252 --> 200 | Recruiting --> Terminated | Trial primary completion date: Aug 2016 --> Nov 2016; Slow enrollment combined with positive preliminary results